Invivyd: Funding, Investors & Team (Sep 2026)
Invivyd is a company that is currently in the commercial stage of development in the biopharmaceutical industry. Their goal is to provide protection against dangerous viral infections through antibody-based therapies. They aim to quickly and continuously provide these treatments to help safeguard at-risk individuals from the harmful effects of various viruses, starting with SARS-CoV-2.
Invivyd has raised $213M across 3 funding rounds on record, the most recent an undisclosed round of $125M announced in Nov 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Invivyd Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Invivyd Funding Rounds
Invivyd raised $30.0M in an undisclosed round announced in Apr 2025.
4 months later, an undisclosed round of $57.5M was announced in Aug 2025.
3 months later, an undisclosed round of $125M was announced in Nov 2025.
Invivyd Founders and Leadership Team
No contact details are on record for this team yet.
Invivyd Funding Compared to Other Biotechnology Startups
Invivyd's latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Invivyd in Biotechnology and Waltham
Companies Similar to Invivyd
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Invivyd Funding FAQs
What does Invivyd do?
Invivyd is a company that is currently in the commercial stage of development in the biopharmaceutical industry. Their goal is to provide protection against dangerous viral infections through antibody-based therapies. They aim to quickly and continuously provide these treatments to help safeguard at-risk individuals from the harmful effects of various viruses, starting with SARS-CoV-2.
How much funding has Invivyd raised?
Invivyd has raised $213M across 3 rounds on record. The most recent is an undisclosed round of $125M announced in Nov 2025.
When did Invivyd last raise funding?
Invivyd's most recent funding round on record is an undisclosed round of $125M, announced in Nov 2025.
Who founded Invivyd?
FundedIQ lists Laura Walker (Founder), Tillman Gerngross (Founder) at Invivyd.
Where is Invivyd headquartered?
Invivyd is based in Waltham, Massachusetts, United States.
How many employees does Invivyd have?
Invivyd is in the 101-250 employee band.
How does Invivyd's funding compare to other Biotechnology startups?
Invivyd's latest round of $125M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Invivyd Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Invivyd is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.